(Q57297479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Mesothelin-family proteins and diagnosis of mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Nicholas de Klerk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

Bruce W S Robinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2

Jenette Creaney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

5

A William Musk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Richard Lake

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Pernilla Winzell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Karl Erik Hellstrom

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ingegerd Hellstrom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

9396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1612-1616

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Multimodality treatment of diffuse malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Clinical Applications of Serum Tumor Markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Appropriateness of prostate-specific antigen testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

The role of tumor markers in gynecologic oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Hyaluronan in pleural effusions and in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Molecular cloning and expression of megakaryocyte potentiating factor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Structure of the Mesothelin/MPF gene and characterization of its promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914794-0

7 January 2021

10.1016/S0140-6736(03)14794-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630441%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference